News

  • Cervical screening interval for women under 50 in England to change from three to five years

    Women aged 25 to 49 in England will be invited for cervical screening every five years instead of three, if they test negative for human papillomavirus (HPV), under new changes beginning 1 July. The update brings England into line with Scotland and Wales, which have already adopted the extended screening interval for women who test [...]

  • Monash IVF admits second embryo mix-up in three months at Australian clinic

    A Victorian woman undergoing IVF treatment received her own embryo instead of her partner’s, Monash IVF has confirmed—marking the second reported mix-up at the fertility company in recent months. The error, which occurred in June, was revealed in a statement to the ASX on Tuesday. Monash IVF said the patient’s embryo was transferred “contrary to [...]

  • Flo Health adopts Databricks to boost AI-powered menstrual cycle tracking

    Femtech company Flo Health has adopted Databricks’ data intelligence platform to strengthen its analytics and AI capabilities, aiming to deliver more personalised menstrual cycle predictions. The period tracking app replaced fragmented systems and legacy infrastructure that had previously limited its ability to scale and deliver cohesive, AI-powered user experiences. The move has helped Flo improve [...]

  • Domestic violence survivors face long-term brain injury and mental health risks, study suggests

    Survivors of domestic violence face a higher risk of brain injury and long-term mental health conditions that can persist for decades after the abuse has ended, new research has found. A new study suggests that among those who suffer physical abuse, repeated head trauma is common—raising the risk of traumatic brain injuries (TBIs) and lasting [...]

  • AI-powered tool boosts skin cancer detection accuracy by 11 per cent, study finds

    A new artificial intelligence tool has improved doctors’ ability to detect skin cancer by 11 per cent, according to research from an international team led by Monash University. The system, named PanDerm, is designed to analyse multiple types of medical images simultaneously to help identify melanoma and other skin diseases more quickly and accurately than [...]

  • Half of UK women have never seen a doctor about menopause, study finds

    Women across the UK are routinely delaying treatment for perimenopause and menopause symptoms - often due to a lack of knowledge, poor health literacy, and uncertainty about where to seek help, new research has revealed. The findings from a survey of 2,000 UK women highlight a significant gap in menopause care and education, with nearly [...]

  • Women, ethnic minorities and people from deprived areas less likely to receive life-saving heart valve treatment – study

    Women, people from ethnic minority backgrounds and those living in the most deprived communities are less likely to receive treatment after a diagnosis of aortic stenosis—a potentially fatal heart valve disease—according to new research. The research highlights serious disparities in care for aortic stenosis, a common and potentially deadly condition if left untreated. The study, [...]

  • Femtech’s next frontier: From buzzword to backbone of women’s health innovation

    Julien de Salaberry, CEO and Founder, Galen Growth, reflects on the findings of a new report quantifying the $360b opportunity in women’s health  In the near decade since “Femtech” was coined, digital health ventures targeting women’s health have evolved from niche apps to a dynamic sector addressing core medical needs.  The Galen Growth newly released [...]

  • Menopause drug may reduce breast cancer growth in postmenopausal women, study finds

    A menopause drug commonly used to relieve symptoms such as hot flushes may also help slow the growth of breast cancer cells in postmenopausal women, according to new clinical trial results. The phase two trial, led by researchers at Northwestern University, found that Duavee—a medication prescribed for menopause-related symptoms—appeared to reduce cell growth in the [...]

  • Digital health failing to capitalise on $360b “ghost market,” research finds

    The health and tech industries are failing to capitalise on a $360bn “ghost market” in women’s health, according to a new report. According to the Galen Growth research, femtech global venture funding reached $2.2bn in 2024, but few digital health ventures are addressing the most common health concerns that impact women, such as cardiovascular disease [...]